Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AETHLON MEDICAL INC Director's Dealing 2012

Aug 6, 2012

35398_dirs_2012-08-06_d35a5123-521e-44a6-a655-7caa1c64a393.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AETHLON MEDICAL INC (AEMD.OB)
CIK: 0000882291
Period of Report: 2012-07-24

Reporting Person: BARRY FRANKLYN S JR (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-07-24 Stock options (right to buy) $0.076 A 460526 Acquired 2022-07-24 Common Stock (460526) Direct

Footnotes

F1: 198,026 options vested on the date of grant, and the balance of 262,500 options will vest at the end of the 2012-2013 fiscal year provided that Mr. Barry has attended at least 80% of the meetings of the Company's Board of Directors during such fiscal year.